These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 28833854)
1. New methods for modelling EQ-5D-5L value sets: An application to English data. Feng Y; Devlin NJ; Shah KK; Mulhern B; van Hout B Health Econ; 2018 Jan; 27(1):23-38. PubMed ID: 28833854 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan. Shiroiwa T; Ikeda S; Noto S; Igarashi A; Fukuda T; Saito S; Shimozuma K Value Health; 2016; 19(5):648-54. PubMed ID: 27565282 [TBL] [Abstract][Full Text] [Related]
3. EQ-5D-5L Valuation for the Malaysian Population. Shafie AA; Vasan Thakumar A; Lim CJ; Luo N; Rand-Hendriksen K; Md Yusof FA Pharmacoeconomics; 2019 May; 37(5):715-725. PubMed ID: 30535779 [TBL] [Abstract][Full Text] [Related]
4. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set. Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730 [TBL] [Abstract][Full Text] [Related]
5. Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L. Hobbins A; Barry L; Kelleher D; Shah K; Devlin N; Goni JMR; O'Neill C Pharmacoeconomics; 2018 Nov; 36(11):1345-1353. PubMed ID: 30051267 [TBL] [Abstract][Full Text] [Related]
6. Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach. Ramos-Goñi JM; Craig BM; Oppe M; Ramallo-Fariña Y; Pinto-Prades JL; Luo N; Rivero-Arias O Value Health; 2018 May; 21(5):596-604. PubMed ID: 29753358 [TBL] [Abstract][Full Text] [Related]
7. Peruvian Valuation of the EQ-5D-5L: A Direct Comparison of Time Trade-Off and Discrete Choice Experiments. Augustovski F; Belizán M; Gibbons L; Reyes N; Stolk E; Craig BM; Tejada RA Value Health; 2020 Jul; 23(7):880-888. PubMed ID: 32762989 [TBL] [Abstract][Full Text] [Related]
8. Test-Retest Reliability of EQ-5D-5L Valuation Techniques: The Composite Time Trade-Off and Discrete Choice Experiments. Purba FD; Hunfeld JAM; Timman R; Iskandarsyah A; Fitriana TS; Sadarjoen SS; Passchier J; Busschbach JJV Value Health; 2018 Oct; 21(10):1243-1249. PubMed ID: 30314626 [TBL] [Abstract][Full Text] [Related]
9. Valuing health-related quality of life: An EQ-5D-5L value set for England. Devlin NJ; Shah KK; Feng Y; Mulhern B; van Hout B Health Econ; 2018 Jan; 27(1):7-22. PubMed ID: 28833869 [TBL] [Abstract][Full Text] [Related]
10. Accounting for Unobservable Preference Heterogeneity and Evaluating Alternative Anchoring Approaches to Estimate Country-Specific EQ-5D-Y Value Sets: A Case Study Using Spanish Preference Data. Ramos-Goñi JM; Oppe M; Estévez-Carrillo A; Rivero-Arias O; Value Health; 2022 May; 25(5):835-843. PubMed ID: 35500952 [TBL] [Abstract][Full Text] [Related]
11. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States. Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663 [TBL] [Abstract][Full Text] [Related]
12. Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L. Ramos-Goñi JM; Rand-Hendriksen K; Pinto-Prades JL Value Health; 2016 Jun; 19(4):478-86. PubMed ID: 27325340 [TBL] [Abstract][Full Text] [Related]
13. Estimating the EQ-5D-5L value set for the Philippines. Miguel RTD; Rivera AS; Cheng KJG; Rand K; Purba FD; Luo N; Zarsuelo MA; Genuino-Marfori AJ; Florentino-Fariñas I; Guerrero AM; Lam HY Qual Life Res; 2022 Sep; 31(9):2763-2774. PubMed ID: 35532835 [TBL] [Abstract][Full Text] [Related]
14. Valuation of the EQ-5D-5L with composite time trade-off for the German population - an exploratory study. Ludwig K; von der Schulenburg JG; Greiner W Health Qual Life Outcomes; 2017 Feb; 15(1):39. PubMed ID: 28219389 [TBL] [Abstract][Full Text] [Related]
15. Efficient Designs for Valuation Studies That Use Time Tradeoff (TTO) Tasks to Map Latent Utilities from Discrete Choice Experiments to the Interval Scale: Selection of Health States for TTO Tasks. Che M; Pullenayegum E Med Decis Making; 2023 Apr; 43(3):387-396. PubMed ID: 36866604 [TBL] [Abstract][Full Text] [Related]
16. Preparatory study for the revaluation of the EQ-5D tariff: methodology report. Mulhern B; Bansback N; Brazier J; Buckingham K; Cairns J; Devlin N; Dolan P; Hole AR; Kavetsos G; Longworth L; Rowen D; Tsuchiya A Health Technol Assess; 2014 Feb; 18(12):vii-xxvi, 1-191. PubMed ID: 24568945 [TBL] [Abstract][Full Text] [Related]
17. Valuing Health State: An EQ-5D-5L Value Set for Ethiopians. Welie AG; Gebretekle GB; Stolk E; Mukuria C; Krahn MD; Enquoselassie F; Fenta TG Value Health Reg Issues; 2020 Sep; 22():7-14. PubMed ID: 31683254 [TBL] [Abstract][Full Text] [Related]
18. Estimating a social value set for EQ-5D-5L in Sweden. Sun S; Chuang LH; Sahlén KG; Lindholm L; Norström F Health Qual Life Outcomes; 2022 Dec; 20(1):167. PubMed ID: 36564844 [TBL] [Abstract][Full Text] [Related]
19. Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values? Mulhern B; Shah K; Janssen MF; Longworth L; Ibbotson R Value Health; 2016; 19(2):210-7. PubMed ID: 27021755 [TBL] [Abstract][Full Text] [Related]
20. Censoring Time Trade-off Values at 0 Versus at -1: How Does the Assumption for Worse-Than-Dead Time Trade-off Values Affect the Modeling of EQ-5D-5L Valuation Data? Yang Z; Rand K; Luo N Value Health; 2023 May; 26(5):685-693. PubMed ID: 36375679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]